To book your place visit: http://marketaccess.eventbrite.co.uk/
A London based event covering the subject of Market access in the Healthcare and Pharmaceutical industries.
An evolving healthcare value environment, driven primarily by saving healthcare costs, challenges the current business model of the biopharmaceuticals industry. It is no surprise that incumbent pharmaceutical players are better prepared to adapt to this evolving and challenging healthcare environment by re-configuring their internal processes and business model.
Market access has traditionally been viewed as a functional area superseding early stage portfolio investment decisions and clinical development. This is not the case anymore as business decisions within Big Pharma must heavily take into account Payers' new incentives to reduce healthcare costs and reward only true innovation.
During this event, we will review this complex and evolving healthcare value environment paying special attention to Market Access as a core capability especially from a small to medium biopharmaceutical company's perspective in achieving competitive advantage.
To book your place visit: http://marketaccess.eventbrite.co.uk/
This event is hosted by the Warwick Life Sciences and Healthcare Professional Network.
Thanks to the British Heart Foundation for providing the venue for this event.